Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.005 USD | +0.08% |
|
-3.31% | +0.56% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.56% | 123.83Cr | |
+14.86% | 12TCr | |
+17.08% | 11TCr | |
+3.38% | 2.26TCr | |
-18.22% | 2.08TCr | |
-15.43% | 1.63TCr | |
-17.05% | 1.62TCr | |
-42.36% | 1.62TCr | |
+0.79% | 1.32TCr | |
+23.10% | 1.11TCr |
- Stock Market
- Equities
- BCRX Stock
- News BioCryst Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc. Receives Health Canada Approval for RAPIVAB® for the Treatment of Influenza